Once-daily intraperitoneal gentamicin is effective therapy for gram-negative CAPD peritonitis
Peritoneal Dialysis International
Saved in:
Main Authors: | Lye, W.-C., Van Der Straaten, J.C., Leong, S.-O., Sivaraman, P., Tan, S.-H., Tan, C.-C., Lee, E.J.C. |
---|---|
Other Authors: | MEDICINE |
Format: | Article |
Published: |
2014
|
Subjects: | |
Online Access: | http://scholarbank.nus.edu.sg/handle/10635/113574 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Institution: | National University of Singapore |
Similar Items
-
Intraperitoneal vancomycin/oral pefloxacin versus intraperitoneal vancomycin/gentamicin in the treatment of continuous ambulatory peritoneal dialysis peritonitis
by: Lye, W.-C., et al.
Published: (2016) -
Optimum serum sampling time for therapeutic monitoring of once-daily gentamicin dosage regimen
by: Nantaka Suntivisut
Published: (2008) -
A study on early onset peritonitis in CAPD patients
by: Gan, H.C., et al.
Published: (2016) -
Pharmacokinetics of once daily intraperitoneal cefazolin in continuous ambulatory peritoneal dialysis patients
by: Low, C.L., et al.
Published: (2014) -
A prospective randomized comparison of single versus multidose gentamicin in the treatment of CAPD peritonitis.
by: Lye, W.C., et al.
Published: (2016)